The rising popularity in GLP-1 agonists for diabetes has sparked a debate about delivery routes : transdermal systems versus capsules. Traditionally , GLP-1 therapies were solely available in oral form, https://shaniamhag094344.mdkblog.com/47090003/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-you